4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Necrostatin-1/AG-CR1-2900-M025/25 mg
商品详细Adipogen/Necrostatin-1/AG-CR1-2900-M025/25 mg
Adipogen/Necrostatin-1/AG-CR1-2900-M025/25 mg
Adipogen/Necrostatin-1/AG-CR1-2900-M025/25 mg
商品编号: AG-CR1-2900-M025
品牌: Adipogen Inc
市场价: ¥2100.00
美元价: 1260.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsNec-1;MTH-Trp;MTH-DL-Tryptophan;Methyl-thiohydantoinDL-tryptophan;5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone
ProductTypeChemical
Properties
FormulaC13H13N3OS
MW259.3
CAS4311-88-0
PurityChemicals≥98%(HPLC)
AppearanceOff-whitetoyellowsolid.
SolubilitySolubleinDMSO,ethanolordimethylformamide.
OtherProductDataNote:1Necrostatin-1issparinglysolubleinaqueousbuffers.Foramaximumsolubilityinaqueousbuffers,itshouldfirstbedissolvedinDMFandthendilutedwiththeaqueousbufferofchoice.Thesolubilityisapproximately0.5mg/mlina1:1solutionofDMF:PBS(pH7.2)usingthismethod.Werecommendtostoreaqueoussolutionsnotlongerthanoneday.

Note:2Insolutiontheproductslightlytautomerizes.Inpolarsolventsthereismoreenolformwhileinnon-polarsolventsthereismoreketoform.
InChiKeyTXUWMXQFNYDOEZ-UHFFFAOYSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepunderinertgas.
Protectfromlight.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Stocksolutionsarestableforatleast3monthswhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Competitiveindoleamine2,3-dioxygenase(IDO)inhibitor[1,4,9,10].
  • Cellpermeable,potentandselectivenecroptosis(anon-apoptoticformofprogrammedcelldeath)inhibitor[2,5].
  • Showedneuroprotectioninamurinemodelofischemicbraininjuryinvivo[2,3].
  • SelectiveandATP-competitivereceptor-interactingproteinkinase1(RIPK1)inhibitor[6,7].
  • UsedininflammatoryanddegenerativediseasemodelstotargetRIPK1[7,9,10].
  • Suppressesautophagyandapoptosisinmurinebraininjurymodels[8,9].
  • Cardioprotectiveandneuroprotective[11-14].
ProductReferences
  1. Inhibitionofindoleamine2,3-dioxygenase,animmunoregulatorytargetofthecancersuppressiongeneBin1,potentiatescancerchemotherapy:A.J.Muller,etal.;Nat.Med.11,312(2005)
  2. Chemicalinhibitorofnonapoptoticcelldeathwiththerapeuticpotentialforischemicbraininjury:A.Degterev,etal.;Nat.Chem.Biol.1,112(2005)
  3. Necrostatin-1protectsagainstglutamate-inducedglutathionedepletionandcaspase-independentcelldeathinHT-22cells:X.Xu,etal.;J.NeuRochem.103,2004(2007)
  4. Clinicalaspectsofindoleamine2,3-dioxygenase(IDO)-initiatedtryptophanmetabolism:IDOisatargetofdrugdiscoveryforvariousdiseasea:O.Takikawa;Int.Congr.Ser.1304,290(2007)
  5. Chemicalgeneticapproachestoprobingcelldeath:B.R.Stockwell&N.M.Gangadhar;Curr.Opin.Chem.Biol.11,83(2007)
  6. IdentificationofRIP1kinaseasaspecificcellulartargetofnecrostatins:A.Degterev,etal.;Nat.Chem.Biol.4,313(2008)
  7. RIP1-dependentandindependenteffectsofnecrostatin-1innecrosisandTcellactivation:Y.Cho,etal.;PLoSOne6,e23209(2011)
  8. Necrostatin-1suppressesautophagyandapoptosisinmicetraumaticbraininjurymodel:Y.Q.Wang,etal.;Neurochem.Res.37,1849(2012)
  9. Necrostatin-1blocksbothRIPK1andIDO:consequencesforthestudyofcelldeathinexperimentaldiseasemodels:P.Vandenabeele,etal.;CellDeathDiffer.20,185(2013)
  10. Activityandspecificityofnecrostatin-1,small-moleculeinhibitorofRIP1kinase:A.Degterev,etal.;CellDeathDiffer20,366(2013)
  11. Studyofcardioprotectiveeffectsofnecroptosisinhibitorsonisolatedratheartsubjectedtoglobalischemia-reperfusion:Y.V.Dimitriev,etal.;Bull.Exp.Biol.Med.155,245(2013)
  12. Necroptosisinhibitornecrostatin-1promotescellprotectionandphysiologicalfunctionintraumaticspinalcordinjury:Y.Wang,etal.;Neuroscience266,91(2014)
  13. Necrostatin-1protectionofdopaminergicneurons;J.R.Wu,etal.;Neural.Regen.Res.10,1120(2015)
  14. Protectiveroleofnecrostatin-1inacutemyocardialinfarction:F.Carbone,etal.;Eur.J.Clin.Invest.46,99(2016)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。